ABSTRACT
Methylation pattern is presented here for first time as a potential molecular marker of changes on SSTR2A and SHP-1(I) gene promoter related to breast and prostate carcinoma. Our results have shown low concordances with SSTR2A and methylated state in prostate cancer and moderate relationship with unmethylated CpG-27 in breast cancer. We found significant concordances for both cancers and SHP-1(I) unmethylation, and increased HER2 expression and SSTR2A methylation in breast cancer. Moreover, we found a correlation between methylation patterns of two genes in normal breast tissue. These data might assist to select subgroups of patients for the administration of alternative therapies.
Subject(s)
Biomarkers, Tumor/genetics , Breast Neoplasms/genetics , DNA Methylation , Prostatic Neoplasms/genetics , Protein Tyrosine Phosphatase, Non-Receptor Type 6/genetics , Receptors, Somatostatin/genetics , Aged , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Female , Humans , Male , Middle Aged , Promoter Regions, Genetic , Prostatic Neoplasms/metabolism , Prostatic Neoplasms/pathology , Protein Isoforms , Receptors, Somatostatin/metabolismABSTRACT
Prostate proliferation is dependent of androgens and many peptide hormones. Recent reports suggest that SSTR2 and SHP-1 were two fundamental components on antiproliferative effect of somatostatin. Many studies on SHP-1 revealed that the expression of this protein was diminished or abolished in several of the cancer cell lines and tissues examined. However, it is necessary to confront the cell lines data with real situation in cancer cases. Our studies have shown that epithelial expressions of both proteins, SHP-1 and SSTR2, in normal and benign hyperplasia are localized in the luminal side of duct and acinar cells. Also, SSTR2 is expressed in stromal cells. In malignant prostate tissue, SHP-1 was diminished in 28/45 cases or absent in 12/45 cases, whereas SSTR2 epithelial was diminished in 38/45 cases or lost in only 2/45 cases. The intensity of immunostained was highly negative correlated with Gleason grade for two proteins.
ABSTRACT
A paracoccidioidomycosis case in a four-year old boy, with fever, lymphadenopathy and hepatosplenomegaly is presented. The diagnosis was confirmed by serology and lymph node biopsy. The patient was treated with amphotericin B. After 48 hours, clinical improvement and considerable adenopathies remission were observed.
Subject(s)
Paracoccidioidomycosis/diagnosis , Biopsy , Child, Preschool , Fever/etiology , Hepatomegaly/etiology , Humans , Lymphatic Diseases/etiology , Lymphatic Diseases/microbiology , Male , Paracoccidioides/isolation & purification , Paracoccidioidomycosis/drug therapy , Paracoccidioidomycosis/microbiology , Paracoccidioidomycosis/pathology , Splenomegaly/etiologyABSTRACT
Se presenta un caso de paracoccidioidomicosis en un niño de cuatro añoscon fiebre, linfadenopatías y hepatosplenomegalia. Se confirmó el diagnósticopor serología e histopatología de biopsia ganglionar. El paciente fue tratadocon anfotericina B. A las 48 h se observó mejoría clínica con una considerableremisión de las adenopatías(AU)
A paracoccidioidomycosis case in a four-year old boy, with fever,lymphadenopathy and hepatosplenomegaly is presented. The diagnosis wasconfirmed by serology and lymph node biopsy. The patient was treated withamphotericin B. After 48 hours, clinical improvement and considerableadenopathies remission were observed(AU)
